Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
FDA Finalizes Guidance on Patient-Focused Drug Development (PFDD) The new PFDD guidance reinforces that clinical trials must capture what matters most to patients symptom burden, quality of life, daily functioning, and treatment tolerability
The results reported that AngIV had a very short half life of less than 2 minutes, however, each of the N-terminal modified compounds, such as Dihexa, exhibited elongated half-lives in comparison to the parent compound
Tubular structures are defined as those with a length four times their width
Studies have shown that GHK-Cu at concentrations of 0.01, 1, and 100 nM significantly increased the production of elastin and collagen in human dermal fibroblasts, which are the cells responsible for building skin structure
US$ 29.00
US$ 25.47
US$ 29.42
US$ 26.11
US$ 22.20
US$ 21.42
US$ 20.30
US$ 21.22
US$ 27.47
